Pharma Market Access Insights - from Mtech Access

64 Epizód

1. Market access in the German speaking markets

   Közzétéve: 2023. 08. 29.
2. The role of nursing in driving digital change in the NHS

   Közzétéve: 2023. 07. 26.
3. Market access for digital therapies and digital medicines

   Közzétéve: 2023. 07. 19.
4. A global market access journey in cannabinoid pharmaceuticals

   Közzétéve: 2023. 06. 17.
5. Primary Care and ICBs – what is the next step in the integration journey?

   Közzétéve: 2023. 05. 15.
6. Data-led transformation in the NHS - partnering to optimise patient care

   Közzétéve: 2023. 03. 31.
7. Innovating for better health – research, collaboration and innovation in the NHS

   Közzétéve: 2023. 03. 07.
8. Healthcare, economics and society – unlocking NHS collaboration

   Közzétéve: 2023. 01. 30.
9. Specialised Commissioning in the NHS – What do you need to know now

   Közzétéve: 2023. 01. 13.
10. Why are we waiting? - Pressures facing the NHS and how to deliver change

    Közzétéve: 2022. 11. 29.
11. Priority setting in primary care - NHS insights

    Közzétéve: 2022. 10. 18.
12. Integrated Care Systems go live in the NHS - reflections after 3 weeks

    Közzétéve: 2022. 08. 09.
13. Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role

    Közzétéve: 2022. 08. 01.
14. Transforming systems and care pathways for an integrated NHS

    Közzétéve: 2022. 06. 21.
15. Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers

    Közzétéve: 2022. 05. 04.
16. Population to Person: How will the NHS translate population health management into impactful, person-centred service change?

    Közzétéve: 2022. 03. 15.
17. Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges?

    Közzétéve: 2022. 02. 11.
18. The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion

    Közzétéve: 2022. 01. 17.
19. Optimising the NHS – How will medicines be valued in integrated systems?

    Közzétéve: 2021. 12. 21.
20. Rare disease market access - strategic and tactical challenges facing orphan medicines entering Europe

    Közzétéve: 2021. 11. 29.